Clinical Crossroads in Ophthalmology™ 2021: Best Practices for Treating Complex Cases of Glaucoma, Ocular Surface Disease, and Diabetic Macular Edema (CME Symposium)
Target Audience
This educational activity is intended for ophthalmologists.
Learning Objectives
After completing this activity, participants will be better able to:
- Use evidence-based treatment strategies for ocular surface disease in patients with other ocular comorbidities
- Adapt long-term treatment strategies for glaucoma and ocular hypertension according to the latest evidence
- Develop long-term management plans for patients with diabetic macular edema who are candidates for intravitreal
corticosteroid treatment
Faculty
Joseph F. Panarelli, MD (Chair)
Associate Professor of Ophthalmology
Chief, Division of Glaucoma Services
Glaucoma Fellowship Director
NYU Langone Eye Center
New York, New York
Sunir J. Garg, MD, FACS
Professor of Ophthalmology
Sidney Kimmel Medical College
Thomas Jefferson University
Attending Physician
Retina Service
Wills Eye Hospital
Philadelphia, Pennsylvania
Sonia H. Yoo, MD
Professor of Ophthalmology
Greentree Hickman Chair in Ophthalmology
Bascom Palmer Eye Institute
University of Miami Miller School of Medicine
Miami, Florida
Disclosure Policy
MedEdicus adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been identified and mitigated by MedEdicus prior to the commencement of the activity.
Faculty
Sunir J. Garg, MD, is a consultant for Allergan, Apellis Pharmaceuticals, Bausch & Lomb Incorporated, Boehringer Ingelheim International GmbH, Johnson & Johnson Vision Care, Inc, Kanaph Therapeutics, and TopiVert Ltd; and is a contracted researcher for Apellis Pharmaceuticals, Boehringer Ingelheim International GmbH, Genentech, Inc, and Regeneron Pharmaceuticals, Inc.
Joseph F. Panarelli, MD, is a consultant for Aerie Pharmaceuticals, Inc, Allergan, CorneaGen, Glaukos Corporation, New World Medical, Inc, and Santen Inc.
Sonia H. Yoo, MD, is a consultant for Alcon, Dompé US, Inc, and Glaukos Corporation.
Peer Reviewer
This activity was peer reviewed. The peer reviewer has no relevant commercial relationships to disclose.
Planners and Managers
MedEdicus planners and managers have no relevant commercial relationships to disclose.
Accreditation Statement
MedEdicus LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
MedEdicus LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Commercial Support
This continuing medical education activity is supported through an educational grant from AbbVie Inc.
Off-Label Discussion
This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.
Provider Contact Information
For questions about this educational activity, please contact MedEdicus LLC at info@mededicus.com.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MedEdicus LLC or AbbVie Inc.
©2021 MedEdicus LLC. 260
Available Credit
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Participation